Chronic migraine (cm): prevalence, headache-related disability and sociodemographic factors in the us population: results from the american migraine prevalence and prevention (ampp) study

被引：0
|
作者：
Buse, D. C. [1 ,2 ]
Reed, M. L. [3 ]
Manack, A. N. [4 ]
Fanning, K. [3 ]
Serrano, D. [3 ]
Turkel, C. C. [5 ]
Lipton, R. B. [1 ,2 ]
机构：
[1] Albert Einstein Coll Med, Neurol, Bronx, NY 10467 USA
[2] Montefiore Med Ctr, Headache, Bronx, NY 10467 USA
[3] Vedanta Res, Hlth Res, Chapel Hill, NC USA
[4] Allergan Pharmaceut Inc, Epidemiol & Populat Hlth, Irvine, CA USA
[5] Allergan Pharmaceut Inc, Res & Dev, Irvine, CA USA
来源：
CEPHALALGIA | 2011年 / 31卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PS1-23
引用
收藏
页码：29 / 30
页数：2
相关论文
共 50 条
  • [41] Acute Treatment Optimization for Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Lipton, R. B.
    Manack, A. N.
    Serrano, D.
    Buse, D. C.
    HEADACHE, 2012, 52 (05): : 873 - 873
  • [42] Impact of NSAID and Triptan Use on Developing Chronic Migraine: Results From the American Migraine Prevalence and Prevention (AMPP) Study
    Lipton, Richard B.
    Serrano, Daniel
    Nicholson, Robert A.
    Buse, Dawn C.
    Runken, M. Chris
    Reed, Michael L.
    HEADACHE, 2013, 53 (10): : 1548 - 1563
  • [43] Medical consultation and headache-impact (hit-6) among persons with chronic migraine (cm) and episodic migraine (em): results from the american migraine prevalence and prevention (ampp) study
    Manack, A. N.
    Buse, D. C.
    Serrano, D.
    Varon, S. F.
    Turkel, C. C.
    Lipton, R. B.
    CEPHALALGIA, 2011, 31 (01) : 29 - 29
  • [44] Prevalence of migraine sufferers who are candidates for preventive therapy: Results from the American Migraine Prevalence and Prevention (AMPP) study
    Silberstein, S
    Diamond, S
    Loder, E
    Reed, ML
    Lipton, RB
    HEADACHE, 2005, 45 (06): : 770 - 771
  • [45] The Relationship of Childhood Maltreatment with Migraine and Tension-Type Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Tietjen, G. E.
    Buse, D. C.
    Fanning, K. M.
    Serrano, D.
    Reed, M. L.
    Lipton, R. B.
    HEADACHE, 2012, 52 (05): : 910 - 910
  • [46] Asthma is a Risk Factor the for Transformation of Episodic to Chronic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Martin, V. T.
    Buse, D. C.
    Fanning, K.
    Serrano, D.
    Reed, M. L.
    Lipton, R. B.
    HEADACHE, 2014, 54 : 40 - 41
  • [47] Persistent Frequent Nausea as a Predictor of Progression to Chronic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Reed, M. L.
    Fanning, K. M.
    Serrano, D.
    Buse, D. C.
    Lipton, R. B.
    CEPHALALGIA, 2013, 33 (S8) : 6 - 6
  • [48] Factors Associated with Triptan Use in Episodic Migraine (EM): Results from the American Migraine Prevalence and Prevention Study (AMPP)
    Chu, M. K.
    Buse, D. C.
    Bigal, M. E.
    Serrano, D.
    Lipton, R. B.
    HEADACHE, 2010, 50 : S25 - S26
  • [49] The Menopausal Transition Is Associated with Higher Headache Frequencies in Women with Migraine: Results of the American Migraine Prevalence and Prevention (AMPP) Study
    Martin, V. T.
    Pavlovic, J.
    Fanning, K.
    Buse, D. C.
    Reed, M.
    Derby, C.
    Lipton, R. B.
    Serrano, D.
    HEADACHE, 2014, 54 : 65 - 66
  • [50] Cost and Predictors of Lost Productive Time in Chronic Migraine and Episodic Migraine: Results from the American Migraine Prevalence and Prevention (AMPP) Study
    Serrano, Daniel
    Manack, Aubrey N.
    Reed, Michael L.
    Buse, Dawn C.
    VaronPhd, Sepideh F.
    Lipton, Richard B.
    VALUE IN HEALTH, 2013, 16 (01) : 31 - 38
12345